How disappointing for hedge fund shorts that they don't
How disappointing for hedge fund shorts that they don't know exactly where the tests are taking place, which makes it more difficult for them to try to get advance information on how they are going. I have posted here before about incidents of things like suborning doctors, nurses, even custodians, to get info.
And how funny that we are getting soft bashing today, all in the tone of "concerns" about what is utterly great news. That news, of course, is that the testing is SUCCESSFUL. If it were not, the lab would not want to apply for grant money to continue testing.
11
1
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Unveiling the New Betblast Features for Gamers In a digital age where online gambling is immensely popular, players are consistently on the lookout for platforms that provide more than just entertainment but also real, significant rewards. One name that has emerged as a favorite among players for offering exceptional wins and rapid payouts is Betblast. As discussions...
Continue Reading
Kinetic Business Introduces an Innovative Internet Solution Kinetic Business is stepping into the spotlight with an exciting new product that caters specifically to the needs of small businesses. Their latest offering, known as Business Ready Internet, aims to revolutionize how small enterprises manage their connectivity, security, and overall operational efficiency....
Continue Reading
Ship-to-Shore Cranes Market Overview As we look towards the future of the Ship-to-Shore (STS) cranes market, predictions indicate a significant expansion, with market size anticipated to reach USD 4.06 billion by 2032. This growth represents a compound annual growth rate (CAGR) of 4.41% from 2025 to 2032. The increasing emphasis on technological advancements in port...
Continue Reading
Chicago Rivet & Machine Co. Announces Dividend Decision Chicago Rivet & Machine Co. (NYSE American: CVR) has made an important announcement regarding its dividend for shareholders. The Board of Directors has declared a quarterly cash dividend of $0.03 per share. This will be paid out to all shareholders who are recorded as of December 5 of the current fiscal year. While...
Continue Reading
Understanding the AstraZeneca PLC Class Action A class action lawsuit has been initiated on behalf of stockholders who purchased shares of AstraZeneca PLC (NASDAQ: AZN) between specific dates. Robbins LLP is actively reminding these investors of the critical lead plaintiff deadline. This class action highlights important allegations surrounding AstraZeneca and offers...
Continue Reading
